M. Bloomston

Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202.

T. McCaffrey, Zhaoqing Yang, Pei-Shan Wang, 2007, Endocrine-related cancer.

Cytopathologic evaluation of the in situ margin in patients undergoing hepatectomy

W. Frankel, P. Wakely, E. Martin, 2012, Cancer cytopathology.

Synergistic Antipancreatic Tumor Effect by Simultaneously Targeting Hypoxic Cancer Cells With HSP90 Inhibitor and Glycolysis Inhibitor

M. Knopp, Tao Zhang, W. Frankel, 2008, Clinical Cancer Research.

Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer.

R. Kloos, M. Ringel, K. Porter, 2010, The Journal of clinical endocrinology and metabolism.

Population Pharmacokinetics of Humanized Monoclonal Antibody HuCC49ΔCH2 and Murine Antibody CC49 in Colorectal Cancer Patients

N. Holford, J. Dalton, E. Martin, 2007, Journal of clinical pharmacology.